Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lanir

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|February 1, 1984
Fusion of plasmacytoma and host cells in vivo: selection of proliferating and nonproliferating culturesR Ber, N Lanir
Harefuah|June 15, 1984
[Fusion of tumor with host cells in vivo]N Lanir, R Ber
Journal of Immunological Methods|April 22, 1985
Cloning of plasmacytoma micrometastases from spleenN Lanir, N Langer, R Ber
Thrombosis Research|March 26, 2005
Hemostasis in normal pregnancyB Brenner, A Aharon, N Lanir
British Journal of Haematology|March 1, 1996
HELLP syndrome associated with factor V R506Q mutationB Brenner, N Lanir, I Thaler
Journal of Immunological Methods|July 6, 1993
Some comments on the Pick and Mizel microassay method for measurement of hydrogen peroxide production by macrophagesE Hoffer, A Tabak, L Shenker, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatmentA Aharon, N Lanir, A Drugan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 27, 2002
Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic eventsI Avivi, N Lanir, R Hoffman, et al.
British Journal of Haematology|July 1, 1996
Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesisB Brenner, S L Vulfsons, N Lanir, et al.
The Journal of Maternal-Fetal Medicine|September 4, 1999
High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal deathH Rothbart, G Ohel, J Younis, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|February 1, 1984
Fusion of plasmacytoma and host cells in vivo: selection of proliferating and nonproliferating culturesR Ber, N Lanir
Harefuah|June 15, 1984
[Fusion of tumor with host cells in vivo]N Lanir, R Ber
Journal of Immunological Methods|April 22, 1985
Cloning of plasmacytoma micrometastases from spleenN Lanir, N Langer, R Ber
Thrombosis Research|March 26, 2005
Hemostasis in normal pregnancyB Brenner, A Aharon, N Lanir
British Journal of Haematology|March 1, 1996
HELLP syndrome associated with factor V R506Q mutationB Brenner, N Lanir, I Thaler
Journal of Immunological Methods|July 6, 1993
Some comments on the Pick and Mizel microassay method for measurement of hydrogen peroxide production by macrophagesE Hoffer, A Tabak, L Shenker, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatmentA Aharon, N Lanir, A Drugan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 27, 2002
Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and may contribute to expression of major thrombotic eventsI Avivi, N Lanir, R Hoffman, et al.
British Journal of Haematology|July 1, 1996
Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesisB Brenner, S L Vulfsons, N Lanir, et al.
The Journal of Maternal-Fetal Medicine|September 4, 1999
High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal deathH Rothbart, G Ohel, J Younis, et al.
Pageof 5